Hypoparathyroidism epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 16: Line 16:
**In Japan, the prevalence of pseudohypoparathyroidism ranges from a low of 26 per 100,000 persons to a high of 42 per 100,000 persons with an average prevalence of 34 per 100,000 persons.<ref name="pmid10695258">{{cite journal |vauthors=Nakamura Y, Matsumoto T, Tamakoshi A, Kawamura T, Seino Y, Kasuga M, Yanagawa H, Ohno Y |title=Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan |journal=J Epidemiol |volume=10 |issue=1 |pages=29–33 |year=2000 |pmid=10695258 |doi= |url=https://www.jstage.jst.go.jp/article/jea1991/10/1/10_1_29/_pdf}}</ref>
**In Japan, the prevalence of pseudohypoparathyroidism ranges from a low of 26 per 100,000 persons to a high of 42 per 100,000 persons with an average prevalence of 34 per 100,000 persons.<ref name="pmid10695258">{{cite journal |vauthors=Nakamura Y, Matsumoto T, Tamakoshi A, Kawamura T, Seino Y, Kasuga M, Yanagawa H, Ohno Y |title=Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan |journal=J Epidemiol |volume=10 |issue=1 |pages=29–33 |year=2000 |pmid=10695258 |doi= |url=https://www.jstage.jst.go.jp/article/jea1991/10/1/10_1_29/_pdf}}</ref>


===Case-fatality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate of [number range]%.
*The case-fatality rate of [disease name] is approximately [number range].
===Age===
===Age===
*Patients of all age groups may develop [disease name].
*Majority of patients with hypoparathyroidism are 45 years or older.<ref name="pmid23737456">{{cite journal |vauthors=Powers J, Joy K, Ruscio A, Lagast H |title=Prevalence and incidence of hypoparathyroidism in the United States using a large claims database |journal=J. Bone Miner. Res. |volume=28 |issue=12 |pages=2570–6 |year=2013 |pmid=23737456 |doi=10.1002/jbmr.2004 |url=}}</ref>
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.  
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].


===Race===
*There is no racial predilection to [disease name].
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
===Gender===
===Gender===
*[Disease name] affects men and women equally.
*Women are more commonly affected by hypoparathyroidism than men. The women to men ratio is approximately 3 to 1.<ref name="pmid23737456">{{cite journal |vauthors=Powers J, Joy K, Ruscio A, Lagast H |title=Prevalence and incidence of hypoparathyroidism in the United States using a large claims database |journal=J. Bone Miner. Res. |volume=28 |issue=12 |pages=2570–6 |year=2013 |pmid=23737456 |doi=10.1002/jbmr.2004 |url=}}</ref>
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
===Region===
*The majority of [disease name] cases are reported in [geographical region].
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
 
===Developed Countries===
 
===Developing Countries===


==References==
==References==

Revision as of 20:35, 18 September 2017

Hypoparathyroidism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypoparathyroidism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypoparathyroidism epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypoparathyroidism epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypoparathyroidism epidemiology and demographics

CDC on Hypoparathyroidism epidemiology and demographics

Hypoparathyroidism epidemiology and demographics in the news

Blogs on Hypoparathyroidism epidemiology and demographics

Directions to Hospitals Treating Hypoparathyroidism

Risk calculators and risk factors for Hypoparathyroidism epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Epidemiology and Demographics

Incidence

  • In Denmark, the incidence of postsurgical hypoparathyroidism is approximately 0.8 per 100,000 person-years.[1]

Prevalence

  • In United States, the prevalence of hypoparathyroidism is approximately 37 per 100,000 person-years.[2]
  • In Denmark, the prevalence of postsurgical hypoparathyroidism is approximately 22 per 100,000 person-years.
  • In Denmark, the prevalance of nonsurgical hypoparathyroidism is approximately 2.3 per 100,000 person-years.[3]
  • In Japan, the prevalence of idiopathic hypoparathyroidism ranges from a low of 55 per 100,000 persons to a high of 88 per 100,000 persons with an average prevalence of 72 per 100,000 persons.[4]
    • In Japan, the prevalence of pseudohypoparathyroidism ranges from a low of 26 per 100,000 persons to a high of 42 per 100,000 persons with an average prevalence of 34 per 100,000 persons.[4]

Age

  • Majority of patients with hypoparathyroidism are 45 years or older.[5]

Gender

  • Women are more commonly affected by hypoparathyroidism than men. The women to men ratio is approximately 3 to 1.[5]

References

  1. Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2013). "Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study". J Bone Miner Res. 28 (11): 2277–85. doi:10.1002/jbmr.1979. PMID 23661265.
  2. Clarke BL, Brown EM, Collins MT, Jüppner H, Lakatos P, Levine MA, Mannstadt MM, Bilezikian JP, Romanischen AF, Thakker RV (2016). "Epidemiology and Diagnosis of Hypoparathyroidism". J. Clin. Endocrinol. Metab. 101 (6): 2284–99. doi:10.1210/jc.2015-3908. PMC 5393595. PMID 26943720.
  3. Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2015). "The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study". J. Bone Miner. Res. 30 (9): 1738–44. doi:10.1002/jbmr.2501. PMID 25753591.
  4. 4.0 4.1 Nakamura Y, Matsumoto T, Tamakoshi A, Kawamura T, Seino Y, Kasuga M, Yanagawa H, Ohno Y (2000). "Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan". J Epidemiol. 10 (1): 29–33. PMID 10695258.
  5. 5.0 5.1 Powers J, Joy K, Ruscio A, Lagast H (2013). "Prevalence and incidence of hypoparathyroidism in the United States using a large claims database". J. Bone Miner. Res. 28 (12): 2570–6. doi:10.1002/jbmr.2004. PMID 23737456.

Template:WH Template:WS